Intensity Modulated Radiotherapy (IMRT) of the Central Nervous System (CNS), Head, Neck, and Thyroid
Customize your policy alerts
Sign up for Blue Cross Blue Shield - North Dakota Policy 164 alerts
Get alerted when Policy 164 changes without checking for updates manually.
Monitor payer policy activity
This policy governs when IMRT for central nervous system, head, neck, and thyroid tumors may be considered medically necessary and applies to provider coverage and prior-authorization requests, subject to applicable contract terms.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.